Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B H Mulsant

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
JAMA|March 20, 2001
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trialH A Sackeim, R F Haskett, B H Mulsant, et al.
Psychological Medicine|September 10, 2015
Neurobiological mechanisms of repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex in depression: a systematic reviewY Noda, W K Silverstein, M S Barr, et al.
Acta Psychiatrica Scandinavica|September 19, 2017
Low medical morbidity and mortality after acute courses of electroconvulsive therapy in a population-based sampleD M Blumberger, D P Seitz, N Herrmann, et al.
The American Journal of Psychiatry|December 10, 1999
PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disordersC C Meltzer, J C Price, C A Mathis, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 12, 2000
Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depressionB G Pollock, R E Ferrell, B H Mulsant, et al.
Journal of Psychiatric Research|May 1, 2019
Getting to precision psychopharmacology: Combining clinical and genetic information to predict fat gain from aripiprazoleH Oughli, E J Lenze, A E Locke, et al.
Molecular Psychiatry|March 6, 2013
The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophreniaT A Lett, M M Chakravarty, M M Chakavarty, et al.
Molecular Psychiatry|October 30, 2013
The SORL1 gene and convergent neural risk for Alzheimer's disease across the human lifespanD Felsky, P Szeszko, L Yu, et al.
Trials|March 6, 2021
Scaling Up Maternal Mental healthcare by Increasing access to Treatment (SUMMIT) through non-specialist providers and telemedicine: a study protocol for a non-inferiority randomized controlled trialD R Singla, S E Meltzer-Brody, R K Silver, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
JAMA|March 20, 2001
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trialH A Sackeim, R F Haskett, B H Mulsant, et al.
Psychological Medicine|September 10, 2015
Neurobiological mechanisms of repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex in depression: a systematic reviewY Noda, W K Silverstein, M S Barr, et al.
Acta Psychiatrica Scandinavica|September 19, 2017
Low medical morbidity and mortality after acute courses of electroconvulsive therapy in a population-based sampleD M Blumberger, D P Seitz, N Herrmann, et al.
The American Journal of Psychiatry|December 10, 1999
PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disordersC C Meltzer, J C Price, C A Mathis, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 12, 2000
Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depressionB G Pollock, R E Ferrell, B H Mulsant, et al.
Journal of Psychiatric Research|May 1, 2019
Getting to precision psychopharmacology: Combining clinical and genetic information to predict fat gain from aripiprazoleH Oughli, E J Lenze, A E Locke, et al.
Molecular Psychiatry|March 6, 2013
The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophreniaT A Lett, M M Chakravarty, M M Chakavarty, et al.
Molecular Psychiatry|October 30, 2013
The SORL1 gene and convergent neural risk for Alzheimer's disease across the human lifespanD Felsky, P Szeszko, L Yu, et al.
Trials|March 6, 2021
Scaling Up Maternal Mental healthcare by Increasing access to Treatment (SUMMIT) through non-specialist providers and telemedicine: a study protocol for a non-inferiority randomized controlled trialD R Singla, S E Meltzer-Brody, R K Silver, et al.
Pageof 10